Clinical Trial Update: Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD) [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating a novel drug for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) has terminated with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) | Phase 2 | Status: TERMINATED | Results posted: 2022-04-04